HKMPY Stock - Hikma Pharmaceuticals PLC
Unlock GoAI Insights for HKMPY
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.13B | $2.88B | $2.52B | $2.55B | $2.34B |
| Gross Profit | $1.42B | $1.41B | $1.24B | $1.30B | $1.20B |
| Gross Margin | 45.3% | 48.9% | 49.2% | 51.0% | 51.3% |
| Operating Income | $612.00M | $367.00M | $282.00M | $582.00M | $579.00M |
| Net Income | $359.00M | $190.00M | $188.00M | $421.00M | $431.00M |
| Net Margin | 11.5% | 6.6% | 7.5% | 16.5% | 18.4% |
| EPS | $3.24 | $1.70 | $1.68 | $3.64 | $3.66 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
Visit WebsiteEarnings History & Surprises
HKMPYEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 24, 2026 | — | — | — | — |
Q3 2025 | Aug 7, 2025 | — | $2.14 | — | — |
Q1 2025 | Feb 26, 2025 | — | $0.59 | — | — |
Q3 2024 | Aug 8, 2024 | — | $1.01 | — | — |
Q2 2024 | Apr 25, 2024 | — | $0.52 | — | — |
Q2 2023 | Jun 30, 2023 | — | $1.18 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.14 | — | — |
Q2 2022 | Jun 30, 2022 | — | $1.52 | — | — |
Q4 2021 | Dec 31, 2021 | — | $1.49 | — | — |
Q2 2021 | Jun 30, 2021 | — | $2.14 | — | — |
Q4 2020 | Dec 31, 2020 | — | $1.84 | — | — |
Q2 2020 | Jun 30, 2020 | — | $1.74 | — | — |
Q4 2019 | Dec 31, 2019 | — | $2.51 | — | — |
Q2 2019 | Jun 30, 2019 | — | $1.52 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.73 | — | — |
Q2 2018 | Jun 30, 2018 | — | $0.44 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-3.80 | — | — |
Q2 2017 | Jun 30, 2017 | — | $0.29 | — | — |
Q4 2016 | Dec 31, 2016 | — | $0.40 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.25 | — | — |
Latest News
Frequently Asked Questions about HKMPY
What is HKMPY's current stock price?
What is the analyst price target for HKMPY?
What sector is Hikma Pharmaceuticals PLC in?
What is HKMPY's market cap?
Does HKMPY pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to HKMPY for comparison